OX40 stimulation is known to enhance activation of effector T cells and to inhibit induction and suppressive function of Treg. Here we uncovered a novel role of OX40 in sustaining Treg competitive fitness in vivo, during repopulation of lymphopenic hosts and reconstitution of BM chimeras. Defective expansion of OX40-null Treg diminished their ability to suppress inflammation in a model of lymphopenia-driven colitis. OX40-mediated promotion of Treg fitness spanned beyond lymphopenic environments, as endogenous Treg in OX40-null mice showed decreased accumulation during thymic development, enhanced susceptibility to antibody-mediated depletion and defective turnover following thymectomy. In vitro, OX40-deficient Treg were found to be intrinsically hyporesponsive to IL-2, in terms of Stat5 phosphorylation and proliferation, according to elevated SOCS1 content and reduced miR155 expression. Therefore, OX40 is a key factor in shaping Treg sensitivity to IL-2 and promoting their proliferation and survival, toward accurate immune regulation.
Introduction
Treg are a specialized subset of CD4 1 T lymphocytes deputed to maintain self-tolerance through inhibition of a variety of immune responses [1] . Dysregulation in functions or numbers of Treg has been associated to severe autoimmunity and inflammation in both mice and humans. Treg selectively express the transcription factor Foxp3, which determines their regulatory program, and constitutively express the a-chain of the IL-2 receptor CD25, which mediates their peripheral homeostasis.
Also, murine Treg constitutively express OX40 [2, 3] , a member of the Tumor Necrosis Factor-Receptor superfamily, encoded by the Tnfrsf4 gene. OX40-null mice show defective T-cell activation and impaired reactivity in multiple settings [4] . Indeed, this receptor intervenes at different checkpoints in shaping optimal immune responses and in counteracting both recessive and dominant tolerance. OX40, expressed on non-Treg upon activation, conveys survival signals [5] , promotes the acquisition of effector functions [6] , impedes and reverts T-cell anergy [7] and even prevents the acquisition of a regulatory phenotype under TGF-b exposure [8, 9] or under Tr1-promoting conditions [10] . A further level of control is represented by the ability of OX40 triggering to inhibit Treg suppressive function in vitro and in vivo, as shown in models of graft-versus-host disease [3] , colitis [2] and cancer immunotherapy [11, 12] . Recently we have found OX40 bridging the bidirectional interaction between Treg and mast cells, leading to blockade of histamine degranulation and anaphylactic response on the mast cell side [13] and to inhibition of suppressive activity on the Treg side [14] .
Little is known about the role of OX40 in Treg development and homeostasis. Young Tnfrsf4 À/À mice show reduced numbers of CD4
1

CD25
1 cells in central and peripheral lymphoid organs [2] , though this observation has not been confirmed at the Foxp3 level. Lymphopenia-driven Treg proliferation is either decreased or increased in OX40L-null or OX40L-transgenic hosts, respectively, indicating a role for OX40 in enhancing Treg proliferation in vivo [2] , but the functional relevance of this finding remains unexplored.
Crucial to Treg homeostasis is the IL-2 signal. In the absence of IL-2 or IL-2 receptor, Treg still develop in the thymus but display a profound defect in peripheral homeostasis [15] . Treg developing from BM cells with impaired/absent IL-2 signal fail to compete in vivo for IL-2 during the reconstitution of lethally irradiated hosts [16, 17] . The transcription factor Stat5, activated by IL-2, directly binds and induces Foxp3 [18] . On the other hand, Foxp3 sustains IL-2 responsiveness by inducing miR155, which inhibits at the post-transcriptional level SOCS1, a major silencer of IL-2 signal [19] .
The signals of OX40 and IL-2 cooperate during the differentiation of conventional T cells into effector cells [20] ; thus a similar interaction may also participate in Treg homeostasis. Indeed, we observed OX40 regulating the competitive fitness of Treg in vivo during repopulation of lymphopenic hosts, reconstitution of BM chimeras and suppression of inflammatory bowel disease. Endogenous Treg in Tnfrsf4 À/À mice show altered accumulation during thymic development, enhanced susceptibility to depletion and defective turnover following thymectomy, suggesting a role for OX40 in promoting Treg proliferation and survival in non-lymphopenic environments. OX40 deficiency is associated with a defective responsiveness to IL-2, in terms of STAT5 phosphorylation and cell proliferation. A higher SOCS1 level, due to a reduced miR155 expression, could account for impaired IL-2 response of OX40-null Treg. Therefore, OX40 sustains Treg fitness by lowering the threshold for IL-2 sensitiveness. 
Results
OX40 promotes Treg competitive fitness in vivo
Foxp3
-cells contaminating the preparation of adoptively transferred cells (around 10%) extensively expanded in the lymphopenic hosts so as to recover the physiological Treg proportion, as previously reported [21] . We found no difference in the homeostatic expansion between WT and Tnfrsf4 À/À nonregulatory cells, indicating that OX40 signal enhanced competitive fitness selectively in Treg (Fig. 1D, right) . Two reports have shown that, following BM transplantation, host Treg surviving irradiation undergo extensive expansion, thus competing with donor-derived Treg, during the reconstitution of the normal Treg pool necessary to prevent lethal autoimmunity [16, 22] . We analyzed the role of OX40 in the ability of developing donor Treg to compete with host residual cells by reconstituting lethally irradiated CD45.1 mice with T-cell-depleted BM cells obtained from scurfy mice, mixed at 4:1 ratio with WT or Tnfrsf4 À/À counterpart ( Fig. 2A ), using a previously described approach [23] that allows, in this combination, to obtain the totality of Treg from WT or Tnfrsf4 À/À BM while the majority of non-regulatory cells from scurfy (OX40-competent) BM. After 8-12 wk, peripheral blood, LN and spleens of all the chimeras showed a physiological Treg frequency (Fig. 2B) . Based on the congenic marker CD45.1, the Treg pool contained a significant proportion of host radioresistant cells, which were OX40-positive, as expected (Fig. 2B) (Fig. 2D, left) . Of note, the Foxp3-negative compartment was replaced with BM-derived cells more efficiently than the Treg compartment and without difference between the two donor types, indicating again that OX40-induced fitness was a Treg-restricted effect (Fig. 2D, right) . Thus, we have characterized the role of OX40 in sustaining Treg competitive fitness during homeostatic proliferation.
Tnfrsf4
À/À Treg show reduced capacity to inhibit lymphopenia-driven colitis significantly lower ability to cure colitis, as recovery of the initial body weight occurred with a significant delay (from d23-d31 to d32-d41 interval) compared with WT Treg-cured controls (Fig. 3A) . On histopathological evaluation untreated mice displayed a severe colitis (median score 4, mean score 3.5070.71) with marked disruption of the glandular epithelium, profound reduction of the goblet cell number and intense inflammatory infiltration involving both mucosa and submucosa. (Fig. 3D ). High Treg frequency was detected also in the mesenteric LN and in the lamina propria of mice treated with WT or OX40-null Treg, in comparison to untreated mice (Fig. 3E ). This suggests that OX40 plays a non-redundant role in early Treg expansion and colitis suppression, and that other signals may overcome OX40 deficiency and rescue Treg fitness and function at later time points.
Beside defective systemic expansion, impaired suppressive function and/or suboptimal recruitment of OX40-null Treg might concur to inefficient inhibition of colitis. Because of the established role of Treg-derived IL-10 in suppressing colitis [26] , we tested whether Tnfrsf4 À/À Treg could have defective suppressive function in vivo as a consequence of reduced IL-10 production. IL-10 intracellular staining performed in Treg re-populating mesenteric LN and colonic lamina propria showed no relevant defect in IL-10 secretion in WT or Tnfrsf4 À/À Treg (Fig. 3E ). To also investigate the possibility of a defective recruitment of Tnfrsf4 À/À Treg to inflamed sites, Treg were stained for CD103, a crucial integrin for gut homing and for immune regulation in the colon [28, 29] . Both WT and OX40-null Treg were found highly expressing CD103 without difference (Fig. 3E) . 
OX40 governs Treg fitness in non-lymphopenic contexts
BM transplantation and T-cell transfer in immunodeficient hosts are characterized by extensive lymphopenia-driven proliferation, a setting that although non-physiological may mirror some therapeutic situations. Nevertheless, to address the contribution of OX40 in shaping the endogenous Treg compartment in immunocompetent mice, we analyzed the frequency of Foxp3 1 T cells in peripheral lymphoid organs and thymuses of WT and Tnfrsf4 À/À mice at different ages. While no difference was found in Treg frequency in LN (Fig. 4A and B The fitness signal triggered by OX40 in Treg may extend beyond proliferation and directly affect their survival under external pressures, for instance mediating their resistance to depletion mediated by anti-CD25 mAb (PC61). Indeed, we observed that Treg resisting PC61-mediated depletion displayed higher expression of OX40 6 days after treatment than untreated Treg (Supporting Information Fig. 1A and B Fig. 2 ). In summary, OX40 supported the fitness of endogenous Treg also in non-lymphopenic hosts, especially when Treg should maximize the response to trophic factors, such as during thymic development and depletion-induced peripheral expansion.
OX40 signal optimizes Treg responsiveness to IL-2 IL-2 is the main cytokine responsible for Treg fitness in vitro and in vivo [30] . We hypothesized that the lower ability of Tnfrsf4
Treg to expand in lymphopenic conditions might result from a defective response to IL-2. WT and Tnfrsf4 À/À Treg were stimulated in vitro with scaled doses of recombinant IL-2 and stained for phosphorylated STAT5 after different time intervals. STAT5 phosphorylation was lower in Tnfrsf4 À/À than in WT Treg, following exposure to different concentrations of IL-2 (Fig. 5A ). This event was more pronounced after 5 or 10 min than after 1 min, suggesting that the defect of OX40-null Treg mainly affected late and sustained, rather than immediate, IL-2 response (Fig. 5B) .
To study whether impaired IL-2 response was correlated to reduced proliferation, we exposed CFSE-labelled WT and Tnfrsf4 À/À Treg to scaled concentrations of IL-2 in the presence of TCR triggering. Without exogenous IL-2, Treg were completely anergic, as previously described [31] . When IL-2 was present, OX40-deficient Treg proliferated with lower efficiency compared with their WT counterparts ( Fig. 5C and D) , in line with the attenuated STAT5 phosphorylation. We checked the expression level of CD25 in WT and Tnfrsf4 À/À Treg, freshly isolated ex vivo or after in vivo expansion, without finding any difference (data not shown). Therefore, we hypothesized that attenuated IL-2 responsiveness in OX40-null Treg might be due to an intrinsic defect in the intracellular machinery leading to STAT5 signaling. SOCS1 is one of the major inhibitors of STAT5 phosphorylation following engagement of IL-2 receptor [32] . Rudensky and colleagues have recently demonstrated that increased expression of SOCS1 is responsible for the diminished competitive fitness of miR155 À/À Treg [19] . Indeed, Foxp3 directly induces miR155 that in turn silences SOCS1 expression, thus enhancing IL-2 signal [19] . To test whether the diminished fitness of Tnfrsf4 À/À Treg involved dysregulation in this pathway, we checked SOCS1 protein level in WT and Tnfrsf4 À/À Treg by Western blot. As controls, naïve and activated T cells were used, expected to express high and low level of SOCS1, respectively. We found Tnfrsf4 À/À Treg expressing an eight-fold higher SOCS1 level than the WT counterpart, while no relevant differences were observed in naïve or activated T cells (Fig. 5E ). In line with this result, real time RT-PCR revealed diminished miR155 amounts in Tnfrsf4
À/À compared with WT Treg (0.8570.10 versus 1.2970.13, po0.01), indicating that miR155 dysregulation may lie behind altered SOCS1 expression and IL-2 response (Fig. 5F ). These data indicate that OX40-null Treg have an intrinsic defect in IL-2 responsiveness because of decreased miR155 content and consequently enhanced SOCS1 expression.
Discussion
OX40 has emerged as a relevant molecule regulating Treg suppressive functions. Several findings suggest that OX40 role in Treg biology may reveal a higher degree of complexity than previously expected [33] . Here we show that OX40 expression has a non-redundant role in supporting Treg competitive fitness in vivo in both lymphopenic and lymphoreplete environments. The underpinning mechanism stems from a constitutive lower sensitivity to IL-2, due to decreased miR155 content and consequently increased SOCS1 expression. Impaired competitive fitness of Tnfrsf4 À/À Treg resulted in their lower efficiency to cure lymphopenia-driven colitis. Indeed, in this model, extensive Treg proliferation occurs in vivo so as to outnumber effector cells and resolve inflammation [25] . However, we cannot exclude that OX40 deficiency may compromise also the intrinsic suppressive function of Treg. For instance, we have shown that Treg suppress histamine degranulation in mast cells through OX40 [13] , and Khazaie and colleagues have demonstrated that adoptively transferred Treg inhibit mastocytosis in colon polyposis [34] , but very little is known about involvement of this pathway in colitis development and resolution. We have checked for IL-10 production, a critical factor in colitis suppression [26, 35, 36] The different outcome could be due to the starting proportion and the nature of competitors that may shift the balance of competition. Indeed OX40-null Treg compete with equal amounts of natural Treg in the former setting, while with a minority of induced Treg in the latter setting. Importantly, natural and induced Treg display a genetically different program that may affect their phenotypic stability in vivo [27] . Many data support the idea that OX40/OX40L drives inflammation in different models of experimental colitis. Dendritic cells highly express OX40L in the mesenteric LN of colitic mice [39] . Blockade of this axis by specific antibodies dramatically reduces T-cell activation and development of colitis, induced by T-cell transfer [39, 40] or dextran sulfate sodium [41] . Tnfrsf4 À/À
T cells are not able to induce colitis into Rag2
À/À mice, and WT T cells failed to induce colitis into OX40L-deficient Rag2 À/À mice, observations that demonstrate that OX40 triggering is crucially required for activation of colitogenic T cells [2] . On the other hand, OX40 triggering inhibits Treg suppression, as demonstrated by the finding that Treg cannot suppress colitis when cotransferred with T cells in transgenic immunodeficient mice expressing OX40L ubiquitously and constitutively [2] . We add here that Tnfrsf4 À/À Treg show diminished ability to cure established colitis, because of an intrinsically defective lymphopenia-driven proliferative response. A previous report highlighted that young OX40-deficient mice have lower counts of CD4 1 CD25 1 T cells in both spleen and thymus [2] . However, a more recent study with Foxp3gfp knock-in mice did not highlight any major defect in Treg frequency in lymphoid organs of OX40-KO mice [9] . According to the latter, we found no difference in Treg frequency or Foxp3 content in spleens or LN of WT and Tnfrsf4
mice. Refined analysis of thymocytes revealed decreased Treg percentage in CD4 single positive, but not double positive, T cells in OX40-null mice. Indeed, OX40 is expressed by developing thymocytes, particularly by Treg precursors, mainly at the single positive stage [42] . OX40 induction in Foxp3 1 thymocytes accompanies high TCR expression and may even precede CD25 up-regulation [42] . Of note, the amount of miR155 is largely expanded in single positive compared with Foxp3 1 double positive thymocytes [19] , indicating that optimal IL-2 responsiveness, settled by OX40, CD25 and miR155 expression, intervenes in shaping Treg thymic pool without compromising early Treg development. This defect is however compensated in the periphery, likely because regulatory thymic emigrants rapidly accumulate under peripheral homeostatic control.
Treg surviving depletion regimens based on polyclonal antilymphocyte serum [43] or cyclophosphamide [12] express higher levels of OX40 than the bulk untreated Treg population. We have confirmed this finding in mice treated with the anti-CD25 antibody PC61, widely used to deplete Treg. PC61 fails to completely eliminate Treg and down-regulates the expression of CD25 in residual Treg [44] . According to previous findings regarding depletion by polyclonal anti-lymphocyte serum [43] , we found OX40-null Treg more susceptible to PC61-induced depletion. We could not formally distinguish whether Treg already expressing high levels of OX40 were protected from depletion, whether Treg surviving depletion up-regulate OX40 to maximize their fitness in vivo or whether OX40-competent Treg proliferate more efficiently in response to depletion. In thymectomized animals, both increased apoptosis and decreased proliferation concurred to the Treg decline observed in Tnfrsf4 À/À mice, suggesting that defec- Foxp3 content at both mRNA and protein level in OX40-triggered Treg [9] . The context of OX40 engagement could also dictate whether intratumoral Treg will be simply inhibited or even eliminated by an OX40 agonist. We have showed that tumor-infiltrating Treg express higher levels of OX40 compared with systemic Treg and that intratumoral injection of an OX40 agonist induced tumor rejection through the inhibition of Treg suppression [14] . Conversely, others have shown that, following cyclophosphamide-based Treg depletion, OX40 is further up-regulated on survived Treg and locally conveys death signals as a result of hyper-activation [12] . It could be speculated that OX40 effects on Treg may span from fitness to inhibition to death in different contexts.
IL-2 regulates the intratumoral balance between Treg and Th17 cells, favouring the former and counterbalancing the latter [45] . Stat5 phosphorylation may dictate the balance between the two lineages, constraining Th17 skewing [46] while supporting Foxp3 expression [18] . OX40 may thus play a role in the Th17-Treg balance in pathological conditions such as cancer and autoimmunity. In a mouse model of CNS-directed autoimmunity, OX40 expression can be detected on Th17 cells [14] .
We have recently shown that Treg directly suppress mast cell degranulation through OX40 [13] . This observation further supports the idea that this molecule may play different roles in Treg suppressive function, depending on the kind of target cells, the strength of stimulation, the cytokine microenvironment, the stability of Foxp3-induced program and the expression of other costimulatory molecules [33] . Intrinsic to the costimulatory nature of OX40 is the fact that, in all the aforementioned contexts, its engagement does not provide an on/off switching effect, but rather a fine-tuning of the cellular response to external challenges.
Materials and methods
Mice and treatments C57BL/6 WT mice were purchased from Charles River (Italy). C57BL/6 CD45.1-congenic mice and Rag1 À/À mice were from Jackson Laboratories. C57BL/6 OX40-deficient mice (Tnfrsf4 À/À )
were from Nigel Killeen (UCSF). Scurfy mice were from Anna Villa (HSR-TIGET, Milan, Italy). Mice were maintained under pathogen-free conditions at the animal facility of Fondazione IRCCS ''Istituto Nazionale dei Tumori''. Animal experiments were authorized by the Institute Ethical Committee and performed in accordance with institutional guidelines and national law (DL116/92). In vivo systemic administration of anti-CD25 mAb (PC61; hybridoma provided by V. Bronte, Padua, Italy) was performed as previously described [11, 13] .
Treg purification and adoptive transfer
Total splenocytes were enriched for T lymphocytes by passing cells on nylon wool columns (Kisker Changes in body weight and clinical symptoms were monitored every 1-2 days. Serum was collected at day 37 upon colitis induction and TNF-a was measured by ELISA (eBioscience). Formalin-fixed, paraffin-embedded colon sections were stained with H&E and colitis severity was graded according to a fourgrade semi-quantitative scoring system. T cells were obtained from mesenteric LN and lamina propria as previously described [26] and analyzed by flow cytometry.
In vitro proliferation assay
Purified CD4 
Western blot
Fresh Treg, naïve and activated CD4 1 T cells were lysed with a chilled lysis buffer (50 mM Hepes, pH 7.0, 0.1% NP-40, 250 mM NaCl, 1 Â Protease Inhibitor Cocktail). Cell debris was removed by centrifugation at 14 000 rpm for 20 min at 41C. Solubilized proteins were separated using SDS-PAGE and transferred to a PVDF membrane. SOCS1 and b-actin were visualized using the antibodies 4H1 (Invitrogen) and A2066 (Sigma), respectively. Densitometric analysis was performed using NIH Image J software.
Real time RT-PCR
Fifty nanograms of total RNA, isolated by using the mirVana miRNA isolation kit (Ambion), were subjected to reverse transcription according to the manufacturer's instructions (Applied Biosystems). Quantitative real time RT-PCR analysis for miR155 was performed according to the TaqMan MicroRNA Assays (Applied Biosystems) and samples normalized by evaluating RNU6 expression. Results were obtained using the comparative Ct method.
Antibodies and flow cytometry
PE-Cy7 anti-CD4 (RM4-5), FITC anti-CD8 (53-6.7), FITC anti-CD25 (PC61), PE anti-OX40 (OX86), FITC anti-CD45.1 (A20), FITC anti-CD45.2 (104), PE anti-CD103 (2E7) were purchased from eBioscience. Surface staining was performed by incubating antibodies at 5 mg/mL on ice for 30 min in PBS containing 2% FBS. Intracellular staining with PE or APC anti-Foxp3 (FJK-16s) was performed according to manufacturer's instructions (eBioscience). For IL-10 and Foxp3 staining, cells obtained from LN and colonic lamina propria were stimulated with 50 ng/mL PMA, 500 ng/mL ionomycin (Sigma-Aldrich) with Monensin (eBioscience) for 4 h at 371C, fixed in Fix/Perm buffer (eBioscience) and stained with APC anti-Foxp3 and PE anti-IL-10 (JES5-16E3, eBioscience). To evaluate Stat5 phosphorylation, Treg were stimulated with rIL-2 (Proleukin) and stained with AlexaFluor488 anti-Stat5 pY694 (clone 47) according to the manufacturer's instructions (BD Bioscience). Flow cytometry data were acquired on a FACSCalibur (Becton Dickinson) and analysed with FlowJo software (version 8.8.4; Treestar).
Statistical analysis
Results are expressed as the means7SD. Data were analyzed using a nonpaired Student's t test (Prism software, GraphPad).
